4-(1H-Indol-3-yl)-Pyrimidin-2-Ylamine Derivatives and Their Use in Therapy

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20090318446A1
SERIAL NO

11794449

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to compounds of formula (I), or pharmaceutically acceptable salts thereof. The present invention seeks to provide further substituted heteroaryl-substituted pyrimidine derivatives. More specifically, the invention relates to compounds that have broad therapeutic applications in the treatment of a number of different diseases and/or that are capable of inhibiting one or more protein kinases.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CYCLACEL LIMITEDLONDON EC2Y 5AU

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Andrews, Matin JI Perk , BE 1 21
Duncan, Kenneth Cambusbarron , GB 10 113
Fischer, Peter Martin Nottingham , GB 36 295
Gibson, Darren Dundee , GB 8 108
Meades, Christopher Dundee , GB 12 119
Wang, Shudong Nottingham , GB 58 382

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation